van Dijken, B.R.J.; Jeltema, H.-R.; Kłos, J.; van Laar, P.J.; Enting, R.H.; Maatman, R.G.H.J.; Bijsterveld, K.; Den Dunnen, W.F.A.; Dierckx, R.A.; Sijens, P.E.;
et al. The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma. Diagnostics 2023, 13, 2791.
https://doi.org/10.3390/diagnostics13172791
AMA Style
van Dijken BRJ, Jeltema H-R, Kłos J, van Laar PJ, Enting RH, Maatman RGHJ, Bijsterveld K, Den Dunnen WFA, Dierckx RA, Sijens PE,
et al. The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma. Diagnostics. 2023; 13(17):2791.
https://doi.org/10.3390/diagnostics13172791
Chicago/Turabian Style
van Dijken, Bart R. J., Hanne-Rinck Jeltema, Justyna Kłos, Peter Jan van Laar, Roelien H. Enting, Ronald G. H. J. Maatman, Klaas Bijsterveld, Wilfred F. A. Den Dunnen, Rudi A. Dierckx, Paul E. Sijens,
and et al. 2023. "The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma" Diagnostics 13, no. 17: 2791.
https://doi.org/10.3390/diagnostics13172791
APA Style
van Dijken, B. R. J., Jeltema, H.-R., Kłos, J., van Laar, P. J., Enting, R. H., Maatman, R. G. H. J., Bijsterveld, K., Den Dunnen, W. F. A., Dierckx, R. A., Sijens, P. E., & van der Hoorn, A.
(2023). The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma. Diagnostics, 13(17), 2791.
https://doi.org/10.3390/diagnostics13172791
